Effects of unrestricted access to flash glucose monitoring in type 1 diabetes.

Published in: Endocrinology, diabetes & metabolism (2020)

Following the introduction of unlimited access, nearly three quarters of the patients were FGM users. Long-term adherence was good, and HbA1c improved in all patients except in those with optimal glycaemic control at baseline.

Keyphrases

type diabetes
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
metabolic syndrome
adipose tissue
patient reported outcomes
glycemic control
patient reported
weight loss